Showing 1 - 10 of 145
Persistent link: https://www.econbiz.de/10011300285
Persistent link: https://www.econbiz.de/10010462784
This paper analyzes the causes and consequences of regional exhaustion of intellectual property, a policy regime under which a set of countries permit parallel imports from one another but not from the rest of the world. A three-country model is developed in which two high-income countries...
Persistent link: https://www.econbiz.de/10010875557
Persistent link: https://www.econbiz.de/10010403044
The aim of this paper is to discuss the common features and specificity of Corporate Social Responsibility (CSR) practices of innovative transnational corporations (TNCs) acting in the pharmaceutical industry. The innovativeness of pharmaceutical firms is understood here as their ability to make...
Persistent link: https://www.econbiz.de/10013204571
Persistent link: https://www.econbiz.de/10012586498
Persistent link: https://www.econbiz.de/10011552915
The aim of this paper is to discuss the common features and specificity of Corporate Social Responsibility (CSR) practices of innovative transnational corporations (TNCs) acting in the pharmaceutical industry. The innovativeness of pharmaceutical firms is understood here as their ability to make...
Persistent link: https://www.econbiz.de/10011960021
This study investigates the returns to R&D for 100 new drugs introduced into the United States during the decade of the 1970s. In contrast to prior studies, it incorporates several significant structural changes that have occurred in the pharmaceutical industry during the 1980s. These include...
Persistent link: https://www.econbiz.de/10009475540
Brazil has evolved strikingly in the last few years in the area of health assistance and access to medicines by its aging and urbanizing population. The government has also set the health industry - which includes pharmaceutical innovation - as one of its strategic sectors to be developed in the...
Persistent link: https://www.econbiz.de/10010330928